193 related articles for article (PubMed ID: 15048090)
1. RRR-alpha-tocopheryl succinate inhibits human prostate cancer cell invasiveness.
Zhang M; Altuwaijri S; Yeh S
Oncogene; 2004 Apr; 23(17):3080-8. PubMed ID: 15048090
[TBL] [Abstract][Full Text] [Related]
2. RRR-alpha-tocopheryl succinate inhibits the proliferation of human prostatic tumor cells with defective cell cycle/differentiation pathways.
Israel K; Sanders BG; Kline K
Nutr Cancer; 1995; 24(2):161-9. PubMed ID: 8584452
[TBL] [Abstract][Full Text] [Related]
3. Alpha-vitamin E derivative, RRR-alpha-tocopheryloxybutyric acid inhibits the proliferation of prostate cancer cells.
Chang E; Ni J; Yin Y; Lin CC; Chang P; James NS; Chemler SR; Yeh S
Asian J Androl; 2007 Jan; 9(1):31-9. PubMed ID: 17187157
[TBL] [Abstract][Full Text] [Related]
4. The therapeutic and preventive effect of RRR-alpha-vitamin E succinate on prostate cancer via induction of insulin-like growth factor binding protein-3.
Yin Y; Ni J; Chen M; DiMaggio MA; Guo Y; Yeh S
Clin Cancer Res; 2007 Apr; 13(7):2271-80. PubMed ID: 17404112
[TBL] [Abstract][Full Text] [Related]
5. 1 alpha,25-Dihydroxyvitamin D (calcitriol) inhibits the invasiveness of human prostate cancer cells.
Schwartz GG; Wang MH; Zang M; Singh RK; Siegal GP
Cancer Epidemiol Biomarkers Prev; 1997 Sep; 6(9):727-32. PubMed ID: 9298581
[TBL] [Abstract][Full Text] [Related]
6. Vitamin E succinate induces apoptosis in human prostate cancer cells: role for Fas in vitamin E succinate-triggered apoptosis.
Israel K; Yu W; Sanders BG; Kline K
Nutr Cancer; 2000; 36(1):90-100. PubMed ID: 10798221
[TBL] [Abstract][Full Text] [Related]
7. Vitamin E succinate inhibits NF-kappaB and prevents the development of a metastatic phenotype in prostate cancer cells: implications for chemoprevention.
Crispen PL; Uzzo RG; Golovine K; Makhov P; Pollack A; Horwitz EM; Greenberg RE; Kolenko VM
Prostate; 2007 May; 67(6):582-90. PubMed ID: 17262802
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo anticancer effects of the novel vitamin E ether analogue RRR-alpha-tocopheryloxybutyl sulfonic acid in prostate cancer.
Ni J; Mai T; Pang ST; Haque I; Huang K; DiMaggio MA; Xie S; James NS; Kasi D; Chemler SR; Yeh S
Clin Cancer Res; 2009 Feb; 15(3):898-906. PubMed ID: 19188160
[TBL] [Abstract][Full Text] [Related]
9. Differential response of human ovarian cancer cells to induction of apoptosis by vitamin E Succinate and vitamin E analogue, alpha-TEA.
Anderson K; Simmons-Menchaca M; Lawson KA; Atkinson J; Sanders BG; Kline K
Cancer Res; 2004 Jun; 64(12):4263-9. PubMed ID: 15205340
[TBL] [Abstract][Full Text] [Related]
10. Effect of hepatocyte growth factor on invasion of prostate cancer cell lines.
Fujiuchi Y; Nagakawa O; Murakami K; Fuse H; Saiki I
Oncol Rep; 2003; 10(4):1001-6. PubMed ID: 12792760
[TBL] [Abstract][Full Text] [Related]
11. 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell invasion via modulation of selective proteases.
Bao BY; Yeh SD; Lee YF
Carcinogenesis; 2006 Jan; 27(1):32-42. PubMed ID: 15987715
[TBL] [Abstract][Full Text] [Related]
12. Differential retention of alpha-vitamin E is correlated with its transporter gene expression and growth inhibition efficacy in prostate cancer cells.
Ni J; Pang ST; Yeh S
Prostate; 2007 Apr; 67(5):463-71. PubMed ID: 17252538
[TBL] [Abstract][Full Text] [Related]
13. Anti-tumor effect of ascorbic acid, lysine, proline, arginine, and epigallocatechin gallate on prostate cancer cell lines PC-3, LNCaP, and DU145.
Roomi MW; Ivanov V; Kalinovsky T; Niedzwiecki A; Rath M
Res Commun Mol Pathol Pharmacol; 2004; 115-116():251-64. PubMed ID: 17564322
[TBL] [Abstract][Full Text] [Related]
14. Gene expression of angiogenic factors correlates with metastatic potential of prostate cancer cells.
Aalinkeel R; Nair MP; Sufrin G; Mahajan SD; Chadha KC; Chawda RP; Schwartz SA
Cancer Res; 2004 Aug; 64(15):5311-21. PubMed ID: 15289337
[TBL] [Abstract][Full Text] [Related]
15. Synergy between selenium and vitamin E in apoptosis induction is associated with activation of distinctive initiator caspases in human prostate cancer cells.
Zu K; Ip C
Cancer Res; 2003 Oct; 63(20):6988-95. PubMed ID: 14583501
[TBL] [Abstract][Full Text] [Related]
16. RRR-alpha-tocopheryl succinate inhibits EL4 thymic lymphoma cell growth by inducing apoptosis and DNA synthesis arrest.
Yu W; Sanders BG; Kline K
Nutr Cancer; 1997; 27(1):92-101. PubMed ID: 8970189
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effects of gamma-tocotrienol on invasion and metastasis of human gastric adenocarcinoma SGC-7901 cells.
Liu HK; Wang Q; Li Y; Sun WG; Liu JR; Yang YM; Xu WL; Sun XR; Chen BQ
J Nutr Biochem; 2010 Mar; 21(3):206-13. PubMed ID: 19195866
[TBL] [Abstract][Full Text] [Related]
18. The influence of CD44v3-v10 on adhesion, invasion and MMP-14 expression in prostate cancer cells.
Harrison GM; Davies G; Martin TA; Mason MD; Jiang WG
Oncol Rep; 2006 Jan; 15(1):199-206. PubMed ID: 16328056
[TBL] [Abstract][Full Text] [Related]
19. A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K/Akt, alphaVbeta3/alphaVbeta5 and MMP-2/-9.
Sun LC; Luo J; Mackey LV; Fuselier JA; Coy DH
Cancer Lett; 2007 Feb; 246(1-2):157-66. PubMed ID: 16644105
[TBL] [Abstract][Full Text] [Related]
20. A novel antisense inhibitor of MMP-9 attenuates angiogenesis, human prostate cancer cell invasion and tumorigenicity.
London CA; Sekhon HS; Arora V; Stein DA; Iversen PL; Devi GR
Cancer Gene Ther; 2003 Nov; 10(11):823-32. PubMed ID: 14605668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
